Studies related to Cognitive Decline and Panax ginseng

An Open-label Trial Of Korean Red Ginseng As An Adjuvant Treatment For Cognitive Impairment In Patients With Alzheimer's Disease

Effect Decrease
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 61
Sex Both Genders
Age Range 65+
Notes for this study:
Korean Red Ginseng was significantly effective in alleviating cognitive side-effects of Alzheimer's disease when taken at 9g for 12 weeks, and although it trended towards significance at 4.5g daily it was not able to confer significant protection